NRG
GEHC icon

Nemes Rush Group’s GE HealthCare GEHC Stock Holding History

Nemes Rush Group’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Sell
234
-23
-9% -$1.51K ﹤0.01% 522
2026
Q1 		$18.3K Buy
257
+20
+8% +$1.58K ﹤0.01% 479
2025
Q4 		$19.4K Buy
237
+16
+7% +$1.25K ﹤0.01% 471
2025
Q3 		$16.6K Sell
221
-609
-73% -$45.4K ﹤0.01% 440
2025
Q2 		$61.5K Hold
830
– – 0.01% 290
2025
Q1 		$67K Sell
830
-19
-2% -$1.63K 0.01% 283
2024
Q4 		$66.3K Buy
849
+611
+257% +$51.9K 0.01% 276
2024
Q3 		$21.7K Sell
238
-262
-52% -$22K ﹤0.01% 337
2024
Q2 		$39K Buy
500
+262
+110% +$21.4K 0.01% 283
2024
Q1 		$21.7K Hold
238
– – ﹤0.01% 368
2023
Q4 		$18.4K Sell
238
-91
-28% -$6.37K ﹤0.01% 354
2023
Q3 		$22.4K Sell
329
-35
-10% -$2.55K ﹤0.01% 329
2023
Q2 		$29.6K Buy
+364
New +$29K 0.01% 319

Other funds holding GEHC

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Nemes Rush Group's GEHC Position: Q2 2026 in Review

Nemes Rush Group reduced its GE HealthCare (GEHC) stake by 8.9% in Q2 2026, selling an estimated $1.51K and leaving 234 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #522.

Nemes Rush Group first reported a position in GEHC in Q2 2023 and has held it in 13 quarters since. The position peaked at $67K in Q1 2025. 1,229 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Nemes Rush Group held 234 shares of GE HealthCare worth $15K as of Q2 2026.
  • Nemes Rush Group sold 23 GE HealthCare shares in Q2 2026, an estimated $1.51K.
  • GE HealthCare made up ﹤0.01% of Nemes Rush Group's portfolio in Q2 2026, its #522 holding.
  • Nemes Rush Group first reported a position in GE HealthCare in Q2 2023 and has held it in 13 quarters since.
  • Nemes Rush Group's GE HealthCare position peaked at $67K in Q1 2025.
  • 1,229 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.